• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Acta Paediatr . SARS-CoV-2 antibodies started to decline just four months after COVID-19 infection in a paediatric population

tetano

Editor, Senior Moderator
Acta Paediatr


. 2021 Jul 15.
doi: 10.1111/apa.16031. Online ahead of print.
SARS-CoV-2 antibodies started to decline just four months after COVID-19 infection in a paediatric population


Adin Breuer[SUP] 1 [/SUP], Allon Raphael[SUP] 1 [/SUP], Hagay Stern[SUP] 1 [/SUP], Ma'aran Odeh[SUP] 1 [/SUP], Judith Fiszlinski[SUP] 1 [/SUP], Nurit Algur[SUP] 2 [/SUP], Sophie Magen[SUP] 2 [/SUP], Orli Megged[SUP] 1 3 4 [/SUP], Yechiel Schlesinger[SUP] 1 3 4 [/SUP], Yuval Barak-Corren[SUP] 1 5 [/SUP], Eyal Heiman[SUP] 1 6 [/SUP]



Affiliations

Abstract

Aim: We evaluated the prevalence of paediatric severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections using antibody testing and characterised antibody titres by time from exposure.
Methods: This was a single-centre, prospective, cross-sectional cohort study. Patients under 18 years old were eligible to participate if they attended the paediatric emergency department at the tertiary Shaare Zedek Medical Center, Jerusalem, Israel, from 18 October 2020 to 12 January 2021 and required blood tests or intravenous access. SARS-CoV-2 seropositivity and antibody levels were tested by a dual-assay model.
Results: The study comprised 1,138 patients (56% male) with a mean age of 4.4 years (interquartile range 1.3-11.3). Anti-SARS-CoV-2 antibodies were found in 10% of the patients. Seropositivity increased with age and 41% of seropositive patients had no known exposure. Children under six years of age had higher initial antibody levels than older children, followed by a steeper decline. The seropositivity rate did not vary during the study, despite schools re-opening. The findings suggest that children's immunity may start falling four months after the initial infection CONCLUSION: Immunity started falling after just four months, and re-opening schools did not affect infection rates. These findings could aid decisions about vaccinating paediatric populations and school closures.

Keywords: antibody levels; asymptomatic infection; coronavirus; immunity; school closures.
 
Back
Top Bottom